跳至主要内容
临床试验/NCT04404712
NCT04404712终止早期 1 期

FAAH Availability in Psychiatric Disorders: A PET Study

Yale University1 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2020年9月23日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
终止
入组人数
6
试验地点
1
主要终点
Total distribution of [11C]MK-3168 in the brain

研究概览

简要总结

The aim of the present study is to examine Fatty Acid Amide Hydrolase (FAAH) availability in humans, including healthy individuals and across a spectrum of psychiatric disorders in which alterations in the endocannabinoid system are observed.

详细描述

This study involves in vivo examination of FAAH availability, implicated both in the pathophysiology and therapeutics of disorders including PTSD, substance use disorders (e.g., alcohol use disorder, cannabis/cannabinoid use disorder, nicotine use disorder), psychotic disorders including schizophrenia, and mood disorders. The endocannabinoid system is a neuromodulatory system that has been implicated across a wide range of psychiatric disorders and may be implicated in the regulation of mood, appetitive behaviors, sleep, and cognition. Thus, alterations in the ECS have wide ranging implications. Finally, the ECS is being explored as a novel therapeutic target for several psychiatric disorders. Additionally, the test/retest reliability of the radiotracer, [11C]MK-3168, will be studied in up to 10 healthy control individuals.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Between the ages of 18 and 65 years, inclusive
  • Good physical health as determined by history, physical and laboratory examinations, ECG, and vital signs
  • PTSD Inclusion Criteria:
  • Diagnosis of Post-Traumatic Stress Disorder
  • AUD Inclusion Criteria:
  • Diagnosis of Alcohol Use Disorder
  • Psychosis Inclusion Criteria:
  • Diagnosis of psychotic disorder such as Schizophrenia, Schizoaffective disorder

排除标准

  • Presence of ferromagnetic metal in the body or heart pacemaker
  • Women with a positive pregnancy test or women who are lactating

研究组 & 干预措施

[11C]MK-3168 PET Scan

Experimental

干预措施: [11C]MK-3168 (Drug)

结局指标

主要结局

Total distribution of [11C]MK-3168 in the brain

时间窗: PET scan day

FAAH availability will be approximated using the FAAH positron emission tomography (PET) tracer \[11C\]MK-3168 total distribution

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohini Ranganathan

Associate Professor of Psychiatry

Yale University

研究点 (1)

Loading locations...

相似试验